SCHEDULE 13G/A 0001404574 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 12/31/2025 0001280776 IMMUNIC, INC. 4525EP101 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 Rule 13d-1(c) 683 CAPITAL MANAGEMENT, LLC DE 0.00 7500000.00 0.00 7500000.00 7500000.00 N 5.9 IA 683 CAPITAL PARTNERS, LP DE 0.00 7500000.00 0.00 7500000.00 7500000.00 N 5.9 PN Zweiman Ari X1 0.00 7500000.00 0.00 7500000.00 7500000.00 N 5.9 IN IMMUNIC, INC. 1200 Avenue of the Americas, Suite 200, New York, New York 10036 683 Capital Management, LLC 683 Capital Partners, LP Ari Zweiman Each of the foregoing is referred to as a "Reporting Person" and collectively as the "Reporting Persons." The principal business address for each of the Reporting Persons is 1700 Broadway, Suite 4200, New York, NY 10019. 683 Capital Management, LLC - DELAWARE 683 Capital Partners, LP - DELAWARE Ari Zweiman - UNITED STATES Y As of December 31, 2025, 683 Capital Partners, LP beneficially owned warrants to purchase 7,500,000 shares of Common Stock which are currently exercisable. 683 Capital Management, LLC, as the investment manager of 683 Capital Partners, LP, may be deemed to have beneficially owned the warrants to purchase 7,500,000 shares of Common Stock beneficially owned by 683 Capital Partners, LP. Ari Zweiman, as the Managing Member of 683 Capital Management, LLC, may be deemed to have beneficially owned the warrants to purchase 7,500,000 shares of Common Stock beneficially owned by 683 Capital Management, LLC. The following percentage is based on 120,284,724 shares of Common Stock outstanding as of November 11, 2025, as reported in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 13, 2025, plus 7,500,000 shares of Common Stock issuable upon exercise of currently exercisable warrants held by the Reporting Persons. As of December 31, 2025, the Reporting Persons may be deemed to have beneficially owned 7,500,000 shares of Common Stock, constituting approximately 5.9% of the outstanding shares of Common Stock. 5.9% See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. Y Y Y N See Exhibit 99.1 to Schedule 13G filed on August 8, 2025. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. 683 CAPITAL MANAGEMENT, LLC /s/ Ari Zweiman 02/17/2026 683 CAPITAL PARTNERS, LP /s/ Ari Zweiman 02/17/2026 Zweiman Ari /s/ Ari Zweiman 02/17/2026